126 related articles for article (PubMed ID: 31191914)
1. What risk of death would people take to be cured of HIV and why? A survey of people living with HIV.
Murray BR; Kratka A; Scherr KA; Eyal N; Blumenthal-Barby J; Freedberg KA; Kuritzkes DR; Hammitt JK; Edifor R; Katz MN; Pollak KI; Zikmund-Fisher BJ; Halpern SD; Barks MC; Ubel PA
J Virus Erad; 2019 Apr; 5(2):109-115. PubMed ID: 31191914
[TBL] [Abstract][Full Text] [Related]
2. "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.
Fridman I; Ubel PA; Blumenthal-Barby J; England CV; Currier JS; Eyal N; Freedberg KA; Halpern SD; Kelley CF; Kuritzkes DR; Le CN; Lennox JL; Pollak KI; Zikmund-Fisher BJ; Scherr KA
AIDS Behav; 2020 Jul; 24(7):2054-2061. PubMed ID: 31900813
[TBL] [Abstract][Full Text] [Related]
3. Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US.
Dubé K; Evans D; Sylla L; Taylor J; Weiner BJ; Skinner A; Thirumurthy H; Tucker JD; Rennie S; Greene SB
J Virus Erad; 2017 Jan; 3(1):40-50.e21. PubMed ID: 28275457
[TBL] [Abstract][Full Text] [Related]
4. If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities: A Qualitative Focus Group Study.
Sylla L; Evans D; Taylor J; Gilbertson A; Palm D; Auerbach JD; Dubé K
AIDS Res Hum Retroviruses; 2018 Jan; 34(1):56-66. PubMed ID: 29198134
[TBL] [Abstract][Full Text] [Related]
5. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
Dubé K; Eskaf S; Evans D; Sauceda J; Saberi P; Brown B; Averitt D; Martel K; Meija M; Campbell D; Barr L; Kanazawa J; Perry K; Patel H; Luter S; Poteat T; Auerbach JD; Wohl DA
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):324-348. PubMed ID: 31608651
[TBL] [Abstract][Full Text] [Related]
6. The willingness of patients with gastroparesis to take risks with medications.
Navas CM; Crowell MD; Lacy BE
Aliment Pharmacol Ther; 2019 Feb; 49(4):429-436. PubMed ID: 30628106
[TBL] [Abstract][Full Text] [Related]
7. HIV Cure Research: Risks Patients Expressed Willingness to Accept.
Kratka A; Ubel PA; Scherr K; Murray B; Eyal N; Kirby C; Katz MN; Holtzman L; Pollak K; Freedburg K; Blumenthal-Barby J
Ethics Hum Res; 2019 Nov; 41(6):23-34. PubMed ID: 31743627
[TBL] [Abstract][Full Text] [Related]
8. Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research.
Bonney EY; Lamptey H; Aboagye JO; Zaab-Yen Abana C; Boateng AT; Quansah DNK; Obo-Akwa A; Ganu VJ; Puplampu P; Kyei GB;
J Virus Erad; 2021 Mar; 7(1):100027. PubMed ID: 33437495
[TBL] [Abstract][Full Text] [Related]
9. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini.
Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P
Elife; 2020 Aug; 9():. PubMed ID: 32831169
[TBL] [Abstract][Full Text] [Related]
10. Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe.
Akinwunmi B; Buchenberger D; Scherzer J; Bode M; Rizzini P; Vecchio F; Roustand L; Nachbaur G; Finkielsztejn L; Chounta V; Van de Velde N
Eur J Public Health; 2021 Jul; 31(3):567-575. PubMed ID: 33462616
[TBL] [Abstract][Full Text] [Related]
11. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.
Proctor VE; Tesfa A; Tompkins DC
AIDS Patient Care STDS; 1999 Sep; 13(9):535-44. PubMed ID: 10813033
[TBL] [Abstract][Full Text] [Related]
12. Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: a cross sectional study from Mbeya and Dar es Salaam regions.
Kagaruki GB; Mayige MT; Ngadaya ES; Kimaro GD; Kalinga AK; Kilale AM; Kahwa AM; Materu GS; Mfinanga SG
BMC Public Health; 2014 Sep; 14():904. PubMed ID: 25183300
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Analysis on Risk Factors for 30-day Readmission Rates in Patients Living With HIV and Severe Major Depression Disorder.
Kompella S; Ikekwere J; Alvarez C; Rutkofsky IH
Cureus; 2021 Jun; 13(6):e15894. PubMed ID: 34249581
[TBL] [Abstract][Full Text] [Related]
14. Physical activity levels among Malawian adults living with HIV and receiving anti-retroviral therapy.
Chisati EM; Munthali F; Constantinou D; Lampiao F
Malawi Med J; 2020 Mar; 32(1):8-12. PubMed ID: 32733653
[TBL] [Abstract][Full Text] [Related]
15. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
Grierson J; Koelmeyer RL; Smith A; Pitts M
HIV Med; 2011 Oct; 12(9):562-9. PubMed ID: 21554524
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with complementary therapy use in people living with HIV/AIDS receiving antiretroviral therapy.
Chang BL; van Servellen G; Lombardi E
J Altern Complement Med; 2003 Oct; 9(5):695-710. PubMed ID: 14629847
[TBL] [Abstract][Full Text] [Related]
17. 'I can coexist with HIV': a qualitative study of perceptions of HIV cure among people living with HIV in Guangzhou, China.
Ma Q; Wu F; Henderson G; Rennie S; Rich ZC; Cheng Y; Hu F; Cai W; Tucker JD
J Virus Erad; 2016 Jul; 2(3):170-4. PubMed ID: 27482457
[TBL] [Abstract][Full Text] [Related]
18. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
Lohse N
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
[TBL] [Abstract][Full Text] [Related]
19. Knowledge and attitudes regarding HIV/AIDS and antiretroviral therapy among patients at a Nigerian treatment clinic.
Olowookere SA; Fatiregun AA; Adewole IF
J Infect Dev Ctries; 2012 Nov; 6(11):809-16. PubMed ID: 23277507
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
